Development of a cobalt(<scp>iii</scp>)-based ponatinib prodrug system

Marlene Mathuber(University of Vienna), Christian R. Kowol(University of Vienna)
Inorganic Chemistry Frontiers
January 1, 2021
10.1039/d1qi00211b
Cited by 20

Related Papers

Liposomal formulations of anticancer copper(<scp>ii</scp>) thiosemicarbazone complexes
|Dalton Transactions|2021|20
Albumin-targeted oxaliplatin(<scp>iv</scp>) prodrugs bearing STING agonists
|Inorganic Chemistry Frontiers|2025|9